Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| NEORX CORP | 398,312 | reported | 04 Feb 2010 | tx 7+393,312 |
| ATAI Life Sciences N.V. | 228,000 | reported | 02 Mar 2022 | tx 3+300,392 |
| ISOLAGEN INC | 165,000 | reported | 17 Jan 2014 | tx 3+175,000 |
| Altimmune, Inc. | 28,078 | reported | 06 Mar 2026 | tx 11+928,450−24,422 |
| SCOLR Pharma, Inc. | 17,500 | reported | 05 Jun 2008 | tx 2+61,667 |
| SENESCO TECHNOLOGIES INC | 11,517 | reported | 15 Mar 2020 | tx 14+901,782−13,302 |
| NASTECH PHARMACEUTICAL CO INC | 8,500 | reported | 09 Jun 2004 | tx 4+30,000 |
| ATOSSA THERAPEUTICS, INC. | 55 | reported | 15 Nov 2023 | tx 27+3,513,420−403,672 |
| SIRNA THERAPEUTICS INC | 0 | reported | 29 Dec 2006 | tx 6+315,000−315,000 |
| Imunon, Inc. | 0 | reported | 19 Mar 2013 | tx 21+324,584−45,908 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 06 Mar 2026 | PURCHASE | Altimmune, Inc. | 5,000 | 3.54 USD | |
| 26 Feb 2026 | GRANT_AWARD | Altimmune, Inc. | 259,000 | 0.00 USD | deriv |
| 26 Feb 2026 | GRANT_AWARD | Altimmune, Inc. | 111,000 | 0.00 USD | deriv |
| 11 Nov 2025 | TAX_WITHHOLDING | Altimmune, Inc. | 5,672 | 4.28 USD | |
| 11 Nov 2025 | EXERCISE | Altimmune, Inc. | 18,750 | 0.00 USD | |
| 11 Nov 2025 | EXERCISE | Altimmune, Inc. | 18,750 | 0.00 USD | deriv |
| 01 Oct 2025 | GRANT_AWARD | Altimmune, Inc. | 57,900 | 0.00 USD | deriv |
| 01 Oct 2025 | GRANT_AWARD | Altimmune, Inc. | 166,800 | 0.00 USD | deriv |
| 13 Mar 2025 | PURCHASE | Altimmune, Inc. | 10,000 | 5.20 USD | first after silence |
| 11 Nov 2024 | GRANT_AWARD | Altimmune, Inc. | 225,000 | 0.00 USD | deriv |
| 11 Nov 2024 | GRANT_AWARD | Altimmune, Inc. | 75,000 | 0.00 USD | deriv |
| 15 Nov 2023 | SALE | ATOSSA THERAPEUTICS, INC. | 50,000 | 0.65 USD | |
| 20 Jun 2023 | PURCHASE | ATOSSA THERAPEUTICS, INC. | 50,000 | 0.97 USD | first after silence |
| 01 Jun 2023 | GRANT_AWARD | ATOSSA THERAPEUTICS, INC. | 2,600,000 | 0.00 USD | deriv |
| 04 May 2023 | GRANT_AWARD | ATOSSA THERAPEUTICS, INC. | 125,000 | 0.00 USD | deriv |
| 13 May 2022 | GRANT_AWARD | ATOSSA THERAPEUTICS, INC. | 50,000 | 0.00 USD | deriv |
| 02 Mar 2022 | GRANT_AWARD | ATAI Life Sciences N.V. | 228,000 | 0.00 USD | deriv |
| 02 Jul 2021 | EXERCISE | ATOSSA THERAPEUTICS, INC. | 45,000 | 2.52 USD | |
| 02 Jul 2021 | EXERCISE | ATOSSA THERAPEUTICS, INC. | 45,000 | 2.38 USD | |
| 02 Jul 2021 | EXERCISE | ATOSSA THERAPEUTICS, INC. | 4,581 | 5.64 USD | |
| 02 Jul 2021 | SALE | ATOSSA THERAPEUTICS, INC. | 107,497 | 5.58 USD | |
| 02 Jul 2021 | EXERCISE | ATOSSA THERAPEUTICS, INC. | 70,000 | 1.70 USD | |
| 02 Jul 2021 | TAX_WITHHOLDING | ATOSSA THERAPEUTICS, INC. | 57,084 | 6.40 USD | |
| 02 Jul 2021 | EXERCISE | ATOSSA THERAPEUTICS, INC. | 45,000 | 0.00 USD | deriv |
| 02 Jul 2021 | EXERCISE | ATOSSA THERAPEUTICS, INC. | 70,000 | 0.00 USD | deriv |
7 purchases reported after at least 12 months of silence — most recent on 13 Mar 2025.